Section Arrow
Quote
LXRX.NASDAQ
- Lexicon Pharmaceuticals
Quotes are at least 15-min delayed:2024/12/23 22:12 EST
Last
 0.827
+0.1123 (+15.71%)
Day High 
0.8429 
Prev. Close
0.7147 
1-M High
1.02 
Volume 
10.34M 
Bid
0.77
Ask
0.8
Day Low
0.6401 
Open
0.6734 
1-M Low
0.6204 
Market Cap 
258.36M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 0.76 
20-SMA 0.76 
50-SMA 1.2 
52-W High 3.73 
52-W Low 0.6204 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.74/-0.31
Enterprise Value
363.13M
Balance Sheet
Book Value Per Share
0.49
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
1.20M
Operating Revenue Per Share
0.00
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
TNXPTonix Pharmaceuticals Holding Corp.0.4031-0.2085-34.09%-- 
RAPTRAPT Therapeutics1.74+0.9146+110.81%-- 
TRAWTraws Pharma Inc12.57+7.55+150.40%-- 
CEROCERo Therapeutics Holdings0.0505-0.0056-9.98%-- 
RXRXRecursion Pharmaceuticals6.99+0.96+15.92%-- 
Quotes are at least 15-min delayed：2024/12/23 22:12 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.